Neuronetics Inc

For the period ended Dec 31, 2023. Filed Mar 8, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 8, 2024

STIM$2.18+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

By:	/s/ Keith J. Sullivan
	Keith J. Sullivan
	President, Chief Executive Officer and Director
Date:	March 7, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date
/s/ Keith J. Sullivan	President, Chief Executive Officer and Director	March 7, 2024
Keith J. Sullivan	(Principal Executive Officer)
/s/ Stephen Furlong	Executive VP, Chief Financial Officer and Treasurer	March 7, 2024
Stephen Furlong	(Principal Financial and Accounting Officer)
/s/ Robert Cascella	Director	March 7, 2024
Robert Cascella
/s/ John Bakewell	Director	March 7, 2024
John Bakewell
/s/ Sheryl Conley	Director	March 7, 2024
Sheryl Conley
/s/ Megan Rosengarten	Director	March 7, 2024
Megan Rosengarten
/s/ Wilfred Jaeger, M.D.	Director	March 7, 2024
Wilfred Jaeger, M.D.
/s/ Glenn Muir	Director	March 7, 2024
Glenn Muir
/s/ Joseph H. Capper	Director	March 7, 2024
Joseph H. Capper

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.